ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1501.xmlIndependent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1501.pdf2026-04-18Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPIhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1490.xmlMaking the Grade: The Impact of Low-Grade Toxicities on Patient Preference for Treatment With Novel Agents2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1490.pdf2026-04-18Making the Grade: The Impact of Low-Grade Toxicities on Patient Preference for Treatment With Novel Agentshttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1453.xmlPaying Less for High-Value Care—Are You Kidding Me?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1453.pdf2026-04-18Paying Less for High-Value Care—Are You Kidding Me?https://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-pxxviii.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-pxxviii.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-plvi.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-plvi.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1475.xmlBreast Cancer, Version 1.20162026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1475.pdf2026-04-18Breast Cancer, Version 1.2016https://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1468.xmlComplete Response to Erlotinib and Bevacizumab in a Patient With Biphenotypic (Hepatobiliary) Primary Liver Carcinoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1468.pdf2026-04-18Complete Response to Erlotinib and Bevacizumab in a Patient With Biphenotypic (Hepatobiliary) Primary Liver Carcinomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1458.xmlToward Personalized Guidelines in Bladder Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1458.pdf2026-04-18Toward Personalized Guidelines in Bladder Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1462.xmlNCCN at 20: Forward Momentum2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1462.pdf2026-04-18NCCN at 20: Forward Momentumhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1534.xmlProstate Cancer Early Detection, Version 2.20152026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1534.pdf2026-04-18Prostate Cancer Early Detection, Version 2.2015https://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1566.xmlPSA Screening for Prostate Cancer: Why Saying No is a High-Value Health Care Choice2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1566.pdf2026-04-18PSA Screening for Prostate Cancer: Why Saying No is a High-Value Health Care Choicehttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1576.xmlThe Case for Tailored Prostate Cancer Screening: An NCCN Perspective2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1576.pdf2026-04-18The Case for Tailored Prostate Cancer Screening: An NCCN Perspectivehttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1510.xmlA Decade of Changes in Preferences for Life-Sustaining Treatments Among Terminally Ill Patients With Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1510.pdf2026-04-18A Decade of Changes in Preferences for Life-Sustaining Treatments Among Terminally Ill Patients With Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1525.xmlScreening Performance for Frailty Among Older Patients With Cancer: A Cross-Sectional Observational Study of Two Approaches2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1525.pdf2026-04-18Screening Performance for Frailty Among Older Patients With Cancer: A Cross-Sectional Observational Study of Two Approacheshttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1585.xmlDatabases as Vehicles for Comparative Effectiveness Research2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/12/article-p1585.pdf2026-04-18Databases as Vehicles for Comparative Effectiveness Research